IMMUNE THROMBOCYTOPENIA (ITP)
Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to calm rogue immune cells in stubborn blood disorders
Disease control Not yet recruitingThis early-phase study tests whether combining two drugs (Zuberitamab and Orelabrutinib) can better control immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA) that haven't responded to other treatments. The drugs work together to stop the immune system from atta…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 26, 2026 07:50 UTC
-
New pill aims to boost platelets in hard-to-treat ITP patients
Disease control Not yet recruitingThis study tests an experimental drug called golidocitinib in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The trial includes 138 participants who have not responded well to standard treatments. The goa…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Engineered immune cells aim to tackle stubborn bleeding disorder
Disease control Not yet recruitingThis early-phase study tests a new treatment called QT-019C for adults with refractory immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The therapy uses specially engineered immune cells from a donor to target and remove fau…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
ITP treatment patterns under the microscope: new study observes Real-World care
Knowledge-focused Not yet recruitingThis study will look back at medical records of 500 people with immune thrombocytopenia (ITP) to see what treatments they received and how well they worked. It includes both treated and untreated patients aged 6 and older. The goal is to understand current treatment practices and…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 26, 2026 07:50 UTC